Figure Legends
Figure 1.  COVID-positive pediatric oncology patients who develop severe cardiorespiratory symptoms have significantly increased cumulative anthracycline exposure and decreased pre-COVID cardioechogram shortening fractions compared to COVID-positive counterparts who did not develop cardiorespiratory symptoms.   Comparison of (A) age, (B) white blood cell count, (C) absolute lymphocyte count, (D) absolute neutrophil count, (E) platelets, (F) cumulative anthracycline exposure, and (G) pre-COVID cardiac echocardiogram shortening fraction in COVID-positive pediatric oncology patients who developed severe and mild clinical symptoms.  Severe cardiorespiratory symptoms as defined by evidence of heart failure and/or intubation secondary to respiratory failure.  Bars = Mean+  SEM.  Points represent values from individual patients.  Shapiro-Wilk normality test was performed on each data set.  The appropriate parametric (student t-test) or non-parametric (Mann-Whitney) test was then used.  ns, non-significant.  *, p<0.05.  **, p<0.01.  ***, p<0.001.